Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. ... | March 27, 2023

Related Keywords

United Kingdom ,Cambridge ,Cambridgeshire ,London ,City Of ,Dan Zacchei ,Erik Schuchard ,Kim Drapkin ,Julie Seidel ,Tanya Joseph ,Giles Roshier ,Rebecca Kral ,Globenewswire Inc ,Concentra Biosciences ,Exchange Commission ,Cowen Execution Services Limited ,Nasdaq ,Jounce Therapeutics Inc ,Redx Pharma Plc ,Capital Partners ,Pharma Plc ,Jounce Board ,Redx Business Combination ,Translational Science ,Financial Adviser ,Investor Relations ,Square Partners ,Execution Services Limited ,Annual Report ,Recommendation Statement ,Restricted Jurisdictions ,Business Day ,Jounce Therapeutics ,Nc Stock Exchange ,News ,Information ,Press Release ,Lot ,Or ,Publication ,Dr ,N ,Whole ,Irectly ,Many ,Jurisdiction ,Ehere ,O ,Would ,Aconstitute ,Violation ,F ,The ,Elevant ,Laws ,Uch Jnce Us4811161011 ,